Hepatocellular carcinoma arising in a telangiectatic hepatocellular adenoma
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 4
Abstract
Telangiectatic hepatocellular adenoma is a rare, recently recognized subtype of benign liver tumor that may very rarely undergo transformation into hepatocellular carcinoma. We report an unusual case of a 75-year-old woman with no history of oral contraceptive use that underwent malignant transformation of a telangiectactic hepatocellular adenoma. No risk factors for adenoma development were identified in this otherwise healthy woman. Radiological characteristics, gross features and histopathology are herein described. In conclusion, telangiectatic hepatocellular adenoma can undergo malignant transformation. Further studies are needed to better clarify the factors associated with malignant progression.
Authors and Affiliations
María Fernanda González-Lara, Juan Carlos Córdova-Ramón, Armando Gamboa-Domínguez, Juan Cosme-Labarthe, Diego Luis Carrillo-Pérez
Leptin in nonalcoholic fatty liver disease
Background: Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition associated with obesity and insulin resistance (IR). Leptin plays a key role in the control of energy balance, and insulin sensitivity. In th...
Routes of transmission of hepatitis C virus
Hepatitis C is one of the most common causes of chronic liver disease in Latin America. It is essential to understand the different mechanisms of transmission of the infection in order to design control measures. The pat...
Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD), an emerging clinical entity with worldwide recognition, is today the most common cause of abnormal liver function tests among adults in the United States. In Mexico City, its pre...
Prevalence of hepatitis B seropositivity among Thai workers in screening program before going abroad.
Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in industrialized countries and is associated with increased risk of cardiovascular, hepatic and metabolic diseases. Molecular mechanisms on the...